CD160 EXPRESSION IN B CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL.).
Deena Elshabrawy, Yasmin Nabil El-Sakhawy, Eman Ismail Ibrahim, M.B.B.Ch, Msc.
Abstract
Open-access reader
Deena Elshabrawy, Yasmin Nabil El-Sakhawy, Eman Ismail Ibrahim, M.B.B.Ch, Msc.
Abstract
Open-access reader
CLL is usually diagnosed through the charachteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in uncertain diagnosis. CD160 is a glycosylphosphatidylinositol-Linked
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
CLL is usually diagnosed through the charachteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in uncertain diagnosis. CD160 is a glycosylphosphatidylinositol-Linked
Key concepts: Chronic lymphocytic leukemia, Leukemia, Medicine, Oncology, Internal medicine, Immunology